Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer

Details for Australian Patent Application No. 2005204017 (hide)

Owner Panacea Biotec Ltd.

Inventors Jindal, Kour Chand; Singh, Sukhjeet; Jain, Rajesh

Agent Watermark

Pub. Number AU-B-2005204017

PCT Pub. Number WO2005/065685

Priority 22/DEL/2004 06.01.04 IN; 27/DEL/2004 06.01.04 IN

Filing date 5 January 2005

Wipo publication date 21 July 2005

Acceptance publication date 31 January 2008

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/43 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/065685 Priority application(s): WO2005/065685

31 January 2008 Application Accepted

  Published as AU-B-2005204017

29 May 2008 Standard Patent Sealed

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005204032-Receiver apparatus, transmitter apparatus, and transmitting/receiving system

2005204016-Non-disintegrating oral solid composition of high dose of water soluble drugs